logo

For the Inventor, By the Inventor

Constance, Germany

Jörg Senn-Bilfinger

This inventor holds 26 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Altana Pharma Ag, Byk Gulden Lomberg Chemische Fabrik Gmbh, Byk Gulden Lomberg Chemische Fabrik Gesellschaft MIT Beschrankter Haftung. Active years: 1982-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jörg Senn-Bilfinger. Retrieved from https://idiyas.com/inventor/jorg-senn-bilfinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 57.7

 

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 153(Granted Patents)


Location History:

  • Konstanz, DE (1992 - 2008)
  • Constance, DE (1982 - 2019)

Company Filing History:

goldMedal12 out of 84 
 
Altana Pharma Ag
 patents
silverMedal11 out of 136 
 
Byk Gulden Lomberg Chemische Fabrik Gmbh
 patents
bronzeMedal2 out of 6 
 
Byk Gulden Lomberg Chemische Fabrik Gesellschaft MIT Beschrankter Haftung
 patents
4. 1 out of 2 
 
Katairo Gmbh
 patents
5. 1 out of 47 
 
Takeda Gmbh
 patents
where one patent can have more than one assignee

Years Active: 1982-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Imidazopyridines
Gastric Secretion Inhibitors
Lipofuscin Diseases
Prodrugs
Tricyclic Compounds
Pyrano Compounds
Helicobacter Control
Pharmaceutical Compositions
Dihydropyrans
Epoxides
Arylalkylthioalkylthiopyridines
Pyridinium Salts
26 patents (USPTO):Explore Patents
1. 10495630 - Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions (2019-12-03),
2. 7393860 - Tetrahydropyridoethers (2008-07-01),
3. 7326718 - 8-Substituted imidazopyridines (2008-02-05),
4. 7314935 - Tricyclic n-acyl compounds (2008-01-01),
5. 7223771 - Tricyclic imidazopyridines (2007-05-29),
6. 7189736 - Prodrugs of imidazopyridine derivatives (2007-03-13),
7. 7141567 - Polysubstituted imidazopyridines as gastric secretion inhibitors (2006-11-28),
8. 7105676 - Tetrahydropyridoethers (2006-09-12),
9. 7034178 - Process for the production of 3-phenylisoserine (2006-04-25),
10. 6936623 - Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders (2005-08-30),
11. 6927292 - Tricyclic epoxides (2005-08-09),
12. 6916825 - Alkylated imidazopyridine derivatives (2005-07-12),
13. 6869949 - Polysubstituted imidazopyridines as gastric secretion inhibitors (2005-03-22),
14. 6162809 - Pyridylthio compounds for controlling helicobacter bacteria (2000-12-19),
15. 6160119 - Fused dihydropyrans (2000-12-12),

Title: Jorg Senn-Bilfinger: Innovator in Chemical Compounds

Introduction

Jorg Senn-Bilfinger is a notable inventor based in Constance, Germany. He has made significant contributions to the field of chemistry, particularly in the development of compounds that target specific bacteria. With a total of 13 patents to his name, Senn-Bilfinger's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents are innovative solutions such as pyridylthio compounds for controlling Helicobacter bacteria and fused dihydropyrans. These inventions showcase his commitment to advancing chemical research and addressing critical health issues.

Career Highlights

Senn-Bilfinger has worked with prominent companies, including Byk Gulden Lomberg Chemische Fabrik GmbH and Byk Gulden Lomberg Chemische Fabrik Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects.

Collaborations

Throughout his career, Senn-Bilfinger has collaborated with esteemed colleagues such as Gerhard Grundler and Bernhard Kohl. These partnerships have fostered a creative environment that has led to numerous successful innovations.

Conclusion

Jorg Senn-Bilfinger is a distinguished inventor whose work in chemical compounds has made a lasting impact. His dedication to innovation and collaboration continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…